IT & Data Management
Blockchain Revolutionizes Pharma Operations And Profits
The pharmaceutical sector happens to be significant for enhancing and sustaining public health. It is responsible when it comes to exploring, developing, producing, as well as marketing drugs and other pharmaceutical products. That said, it faces loads of challenges...
Drug Research
Safe And Efficient Gene Editing With Virus-Derived Peptides
A novel approach within the genetic engineering of cells promises major enhancements when it comes to speed, effectiveness, and reduction in cellular toxicity as compared to the current methods. The approach could also go on to power advanced cell...
Drug Research
Complexity of APIs Drive OSD Contract Manufacturing Demand
For many years, the rising complexity of APIs has led to the development of a sea of novel formulations that help in the efficient delivery of drugs to the intended site where action needs to happen. Nevertheless, the demand...
Clinical Trials
FDA Releases Draft Guidance On Decentralized Clinical Trials
US Food and Drug Administration has come up with a novel draft guidance in order to further support the use of decentralised clinical trials when it comes to drugs, biologics, and devices. The publication has in it recommendations from...
IT & Data Management
Digital Bioprocessing Is Set To Improve Drug Product Quality
One of the market reports has gone on to show that the digital biomanufacturing segment is expected to grow at a CAGR of 11% between 2023 and 2035 and will be driven largely by digital transformation.
The influencing factors identified...
Drug Research
European Medicines Agency recommends bimekizumab in two new indications
UCB, a global biopharmaceutical company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued positive opinions recommending granting marketing authorization for bimekizumab in the European Union (EU) for the...
Drug Research
FDA approves the manufacture of new microbiome-based therapeutic VOWSTTM at Recipharm site
Recipharm, a Global contract development and manufacturing organization (CDMO), has announced today that its subsidiary, GenIbet Biopharmaceuticals, has been approved by the US FDA as a manufacturing site of VOWST, a breakthrough orally administered fecal microbiota product for the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read